Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Progression, recovery and fatality in patients with SARS-CoV-2 related pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Yirong Lu, Qingquan Lv, Xiping Wu, Tian Hu, Kai Wang, Yumei Liu, Yuhai Hu, Lan Yu, Hexuan Fei, Zheng Ba, Xiaohua Lin, Hua Wang
doi: https://doi.org/10.1101/2020.05.12.20099739
Yirong Lu
1Department of Intensive Care Medicine, Southern Medical University Zhujiang Hospital, Guangzhou 510282, Guangdong, China
2Department of Respiratory and Critical Care Medicine, Southern Medical University Zhujiang Hospital, Guangzhou 510282, Guangdong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qingquan Lv
3Department of Medical Affairs, Hankou Hospital, Wuhan 430010, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiping Wu
2Department of Respiratory and Critical Care Medicine, Southern Medical University Zhujiang Hospital, Guangzhou 510282, Guangdong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tian Hu
4Department of Respiratory Medicine, Hankou Hospital, Wuhan 430010, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Wang
1Department of Intensive Care Medicine, Southern Medical University Zhujiang Hospital, Guangzhou 510282, Guangdong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: icuwanghua@163.com
Yumei Liu
4Department of Respiratory Medicine, Hankou Hospital, Wuhan 430010, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhai Hu
5Department of Laboratory Medicine, Hankou Hospital, Wuhan 430010, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lan Yu
6Department of Radiology, Hankou Hospital, Wuhan 430010, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hexuan Fei
6Department of Radiology, Hankou Hospital, Wuhan 430010, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zheng Ba
1Department of Intensive Care Medicine, Southern Medical University Zhujiang Hospital, Guangzhou 510282, Guangdong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaohua Lin
1Department of Intensive Care Medicine, Southern Medical University Zhujiang Hospital, Guangzhou 510282, Guangdong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Wang
1Department of Intensive Care Medicine, Southern Medical University Zhujiang Hospital, Guangzhou 510282, Guangdong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objectives To determine the case fatality rates and death risk factors.

Design Retrospective case series.

Setting A COVID-19 ward of a secondary Hospital in Wuhan, China.

Participants Consecutively hospitalized COVID-19 patients between Jan 3, 2020 and Feb 27, 2020. Outcomes were followed up to discharge or death.

Results Of 121 patients included, 66 (54.6%) were males. The median age was 59 (IQR: 46 to 67) years, and hypertension (33 patients; 27.3%) the leading comorbidity. Lymphopenia (83 of 115 patients; 72.2%) frequently occurred and then normalized on day 4 (IQR: 3 to 6) after admission in the survivors, with lung lesion absorbed gradually on day 8 (IQR: 6 to10) after onset (33 of 57 patients; 57.9%). The real-time polymerase chain reaction (RT-PCR) assays for SARS-CoV-2 were positive in 78 (78/108; 72.2%) patients, and a false-negative RT-PCR occurred in 15 (13.9%) patients. Hypoxemia occurred in 94 (94/117; 80.3%) patients, and supplemental oxygen was given in 88 (72.7%) patients, and mon-invasive or invasive ventilation in 20 (16.5%) cases. Corticosteroid use might link to death. The case fatality rates were 4.4% (one of 23 patients), 29.3% (12/41), 22.8% (13/57) or 45% (9/20) for patients with moderate, severe, critical illness or on ventilator. The length of hospital stay was 14 (IQR: 10 to 20) days, and selfcare ability worsened in 21 patients (21/66; 31.8%) cases. Patients over 60 years were most likely to have poorer outcomes, and increasing in age by one-year increased risk for death by 18% (CI: 1.04-1.32).

Conclusions In management of patients with SARS-CoV-2 pneumonia, especially the elderly with hypertension, close monitoring and appropriate supportive treatment should be taken earlier and aggressively to prevent from developing severe or critical illness. Corticosteroid use might link to death. Repeated RT-PCR tests or novel detection methods for SARS-CoV-2 should be adopted to improve diagnostic efficiency.

Strengths and limitations of this study

  • ➢ Eight case series reported mortality of 6.2% to 61.5% in COVID-19 patients in Wuhan, China. However, outcomes were inadequately followed and the risk factors for death unrevealed.

  • ➢ The case fatality rates were 4.4%, 29.3%, 22.8% or 45% for patients with moderate, severe, critical illness or on ventilator.

  • ➢ Age was the independent factor for death, and an increase by one-year increased risk for death by 18% (odds ratio: 1.18; 95% CI: 1.04-1.32; P < .01).

  • ➢ Case fatality rates calculated might be affected by small patient subset size and non-prospective data collection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education (grant number: LC2016PY036 to Dr Wang). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study will be entered online and deposited on the International Severe Acute Respiratory and Emerging Infection Consortium Data Platform (ISARIC DP) at https://ncov.medsci.ox.ac.uk/, hosted by the University of Oxford. The data will be made available on reasonable requests to the corresponding author. A proposal with detailed description of study objectives and statistical analysis plan would be needed for evaluation of the reasonability of requests. Additional materials might also be required during the process of evaluation. Participant data in the form of pseudonymization will be provided after approval from the corresponding author and Wuhan Hankou Hospital.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Progression, recovery and fatality in patients with SARS-CoV-2 related pneumonia in Wuhan, China: a single-centered, retrospective, observational study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Progression, recovery and fatality in patients with SARS-CoV-2 related pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Yirong Lu, Qingquan Lv, Xiping Wu, Tian Hu, Kai Wang, Yumei Liu, Yuhai Hu, Lan Yu, Hexuan Fei, Zheng Ba, Xiaohua Lin, Hua Wang
medRxiv 2020.05.12.20099739; doi: https://doi.org/10.1101/2020.05.12.20099739
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Progression, recovery and fatality in patients with SARS-CoV-2 related pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Yirong Lu, Qingquan Lv, Xiping Wu, Tian Hu, Kai Wang, Yumei Liu, Yuhai Hu, Lan Yu, Hexuan Fei, Zheng Ba, Xiaohua Lin, Hua Wang
medRxiv 2020.05.12.20099739; doi: https://doi.org/10.1101/2020.05.12.20099739

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (195)
  • Anesthesia (54)
  • Cardiovascular Medicine (489)
  • Dentistry and Oral Medicine (89)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5674)
  • Forensic Medicine (3)
  • Gastroenterology (215)
  • Genetic and Genomic Medicine (863)
  • Geriatric Medicine (88)
  • Health Economics (230)
  • Health Informatics (761)
  • Health Policy (390)
  • Health Systems and Quality Improvement (250)
  • Hematology (105)
  • HIV/AIDS (182)
  • Infectious Diseases (except HIV/AIDS) (6467)
  • Intensive Care and Critical Care Medicine (390)
  • Medical Education (117)
  • Medical Ethics (28)
  • Nephrology (90)
  • Neurology (846)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (162)
  • Occupational and Environmental Health (258)
  • Oncology (514)
  • Ophthalmology (163)
  • Orthopedics (44)
  • Otolaryngology (105)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (250)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (113)
  • Psychiatry and Clinical Psychology (963)
  • Public and Global Health (2224)
  • Radiology and Imaging (376)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (312)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)